4//SEC Filing
Kyme Pierre 4
Accession 0001104659-25-010561
CIK 0000921114other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:19 PM ET
Size
5.6 KB
Accession
0001104659-25-010561
Insider Transaction Report
Form 4
Kyme Pierre
Chief Business Officer
Transactions
- Award
Stock Options (Right to Buy)
2025-02-05+100,000→ 100,000 totalExercise: $2.04Exp: 2035-02-05→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the Stock Options shall vest on February 5th of each of 2026, 2027, 2028 and 2029, in each case subject to continuous service through the applicable vesting date.
Documents
Issuer
Armata Pharmaceuticals, Inc.
CIK 0000921114
Entity typeother
Related Parties
1- filerCIK 0002028892
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:19 PM ET
- Size
- 5.6 KB